Beovu Dosage
Generic name: brolucizumab-dbll
Dosage form: intravitreal injection
Drug class: Anti-angiogenic ophthalmic agents
Medically reviewed by A Ras MD.
Adult Dosing
Dosage forms: INJ (pre-filled syringe): 6 mg per 0.05 mL; INJ (vial): 6 mg per 0.05 mL
Special Note
- [formulation clarification]
- Info: nonproprietary name = brolucizumab-dbll
Age-related macular degeneration, neovascular
6 mg intravitreally q8-12wk
- Start: 6 mg intravitreally qmo x3 doses
Diabetic macular edema
6 mg intravitreally q8-12wk
- Start: 6 mg intravitreally q6wk x5 doses
Renal dosing
[no adjustment]
- renal impairment: no adjustment
- HD/PD: no adjustment; no supplement
Hepatic dosing
- no adjustment
SRC: NLM .